Lobular Breast Cancer Research Program - Homepage
Rita Mukhtar, MD
Principal Investigator, Lobular Breast Cancer Research Program
Associate Professor of Surgery
Division of Surgical Oncology
The Lobular Breast Cancer Research Program is the first research program in California dedicated to understanding invasive lobular carcinoma (ILC) and advancing lobular-specific research with the aim to pursue breakthroughs that improve patient lives and outcomes. Our research is supported by The Helen Diller Family Comprehensive Cancer Center and the American Cancer Society, as well as directly by patients and the wider community.
Mission
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer and accounts for 10-15% of the 280,000 annual cases in the United States. ILC is an understudied breast cancer, and currently there are no specific treatment strategies designed for this unique breast cancer subtype, despite high long-term risk of recurrence. The Lobular Breast Cancer Research Program is committed to addressing the critical gap in ILC diagnostic and treatment strategies.
Support our Research
A gift to the Lobular Breast Cancer Research Program supports our efforts to advance ILC research and innovate targeted treatments that improve patient lives and outcomes.
We are working to contribute to a future where people don’t develop and die from ILC.